» Articles » PMID: 31961419

Effect of Early Surgery Vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial

Abstract

Importance: For patients with painful chronic pancreatitis, surgical treatment is postponed until medical and endoscopic treatment have failed. Observational studies have suggested that earlier surgery could mitigate disease progression, providing better pain control and preserving pancreatic function.

Objective: To determine whether early surgery is more effective than the endoscopy-first approach in terms of clinical outcomes.

Design, Setting, And Participants: The ESCAPE trial was an unblinded, multicenter, randomized clinical superiority trial involving 30 Dutch hospitals participating in the Dutch Pancreatitis Study Group. From April 2011 until September 2016, a total of 88 patients with chronic pancreatitis, a dilated main pancreatic duct, and who only recently started using prescribed opioids for severe pain (strong opioids for ≤2 months or weak opioids for ≤6 months) were included. The 18-month follow-up period ended in March 2018.

Interventions: There were 44 patients randomized to the early surgery group who underwent pancreatic drainage surgery within 6 weeks after randomization and 44 patients randomized to the endoscopy-first approach group who underwent medical treatment, endoscopy including lithotripsy if needed, and surgery if needed.

Main Outcomes And Measures: The primary outcome was pain, measured on the Izbicki pain score and integrated over 18 months (range, 0-100 [increasing score indicates more pain severity]). Secondary outcomes were pain relief at the end of follow-up; number of interventions, complications, hospital admissions; pancreatic function; quality of life (measured on the 36-Item Short Form Health Survey [SF-36]); and mortality.

Results: Among 88 patients who were randomized (mean age, 52 years; 21 (24%) women), 85 (97%) completed the trial. During 18 months of follow-up, patients in the early surgery group had a lower Izbicki pain score than patients in the group randomized to receive the endoscopy-first approach group (37 vs 49; between-group difference, -12 points [95% CI, -22 to -2]; P = .02). Complete or partial pain relief at end of follow-up was achieved in 23 of 40 patients (58%) in the early surgery vs 16 of 41 (39%)in the endoscopy-first approach group (P = .10). The total number of interventions was lower in the early surgery group (median, 1 vs 3; P < .001). Treatment complications (27% vs 25%), mortality (0% vs 0%), hospital admissions, pancreatic function, and quality of life were not significantly different between early surgery and the endoscopy-first approach.

Conclusions And Relevance: Among patients with chronic pancreatitis, early surgery compared with an endoscopy-first approach resulted in lower pain scores when integrated over 18 months. However, further research is needed to assess persistence of differences over time and to replicate the study findings.

Trial Registration: ISRCTN Identifier: ISRCTN45877994.

Citing Articles

Endoscopic Management of Benign Pancreaticobiliary Disorders.

Vedamurthy A, Krishnamoorthi R, Irani S, Kozarek R J Clin Med. 2025; 14(2).

PMID: 39860499 PMC: 11766296. DOI: 10.3390/jcm14020494.


Minimally invasive versus open lateral pancreaticojejunostomy in patients with painful chronic pancreatitis: systematic review.

Montorsi R, Francken M, Boermeester M, Busch O, Daams F, Hackert T BJS Open. 2025; 9(1).

PMID: 39835446 PMC: 11747668. DOI: 10.1093/bjsopen/zrae135.


Chronic and Idiopathic Pancreatitis-A Personalized Treatment Approach.

von Widdern J, Rosendahl J, Ammer-Herrmenau C United European Gastroenterol J. 2024; 13(1):116-124.

PMID: 39704081 PMC: 11866313. DOI: 10.1002/ueg2.12741.


Total pancreatectomy with islet cell auto-transplantation for chronic pancreatitis: sustaining long-term glycemic health with or without graft function.

Desai C Hepatobiliary Surg Nutr. 2024; 13(6):1068-1070.

PMID: 39669065 PMC: 11634418. DOI: 10.21037/hbsn-24-620.


PANCREATODUODENECTOMY AS TREATMENT FOR RECURRENT ACUTE PANCREATITIS DUE TO PANCREAS DIVISUM.

Silva E, Silva M, Araujo M, Paulino B, Moraes-Junior J, Torres O Arq Bras Cir Dig. 2024; 37:e1834.

PMID: 39630835 PMC: 11654164. DOI: 10.1590/0102-6720202400040e1834.


References
1.
Nealon W, Matin S . Analysis of surgical success in preventing recurrent acute exacerbations in chronic pancreatitis. Ann Surg. 2001; 233(6):793-800. PMC: 1421322. DOI: 10.1097/00000658-200106000-00009. View

2.
Gardner T, Kennedy A, Gelrud A, Banks P, Vege S, Gordon S . Chronic pancreatitis and its effect on employment and health care experience: results of a prospective American multicenter study. Pancreas. 2010; 39(4):498-501. DOI: 10.1097/MPA.0b013e3181c5c693. View

3.
Ali U, Nieuwenhuijs V, Van Eijck C, Gooszen H, M van Dam R, Busch O . Clinical outcome in relation to timing of surgery in chronic pancreatitis: a nomogram to predict pain relief. Arch Surg. 2012; 147(10):925-32. DOI: 10.1001/archsurg.2012.1094. View

4.
Ali U, Issa Y, Bruno M, Goor H, Van Santvoort H, Busch O . Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial. BMC Gastroenterol. 2013; 13:49. PMC: 3610165. DOI: 10.1186/1471-230X-13-49. View

5.
Beger H, Krautzberger W, Bittner R, Buchler M, Limmer J . Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis. Surgery. 1985; 97(4):467-73. View